Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Nutt

Showing results (101-110 of 389) with videos related to

Pageof 39
Sort By:
The International Journal of Neuropsychopharmacology|December 6, 2002
Generalized anxiety disorder: comorbidity, comparative biology and treatmentDavid J Nutt, James C Ballenger, David Sheehan, et al.
British Journal of Clinical Pharmacology|May 8, 2026
Exploring new avenues: Psychedelic-assisted therapy for young peopleIoanna Artemis Vamvakopoulou, Dasha Nicholls, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular functionAndrew Smith, Carolyn Brice, Jon Nash, et al.
Psychopharmacology|March 17, 2006
Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopramInnar Tõru, Jakov Shlik, Eduard Maron, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Amphetamine, past and present--a pharmacological and clinical perspectiveDavid J Heal, Sharon L Smith, Jane Gosden, et al.
Advances in Pharmacology (San Diego, Calif.)|July 27, 2010
GABAB receptors in addiction and its treatmentRobin J Tyacke, Anne Lingford-Hughes, Laurence J Reed, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 8, 2006
Human taste thresholds are modulated by serotonin and noradrenalineTom P Heath, Jan K Melichar, David J Nutt, et al.
Neuropharmacology|May 3, 2021
Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeuticsAnne Katrin Schlag, Saoirse E O'Sullivan, Rayyan R Zafar, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary CareJames C. Ballenger, Jonathan R. T. Davidson, Yves Lecrubier, et al.
The Lancet. Psychiatry|September 12, 2015
Attacks on antidepressants: signs of deep-seated stigma?David J Nutt, Guy M Goodwin, Dinesh Bhugra, et al.
Pageof 39

Showing results (101-110 of 389) with videos related to

Sort By:
Pageof 39
The International Journal of Neuropsychopharmacology|December 6, 2002
Generalized anxiety disorder: comorbidity, comparative biology and treatmentDavid J Nutt, James C Ballenger, David Sheehan, et al.
British Journal of Clinical Pharmacology|May 8, 2026
Exploring new avenues: Psychedelic-assisted therapy for young peopleIoanna Artemis Vamvakopoulou, Dasha Nicholls, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular functionAndrew Smith, Carolyn Brice, Jon Nash, et al.
Psychopharmacology|March 17, 2006
Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopramInnar Tõru, Jakov Shlik, Eduard Maron, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Amphetamine, past and present--a pharmacological and clinical perspectiveDavid J Heal, Sharon L Smith, Jane Gosden, et al.
Advances in Pharmacology (San Diego, Calif.)|July 27, 2010
GABAB receptors in addiction and its treatmentRobin J Tyacke, Anne Lingford-Hughes, Laurence J Reed, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 8, 2006
Human taste thresholds are modulated by serotonin and noradrenalineTom P Heath, Jan K Melichar, David J Nutt, et al.
Neuropharmacology|May 3, 2021
Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeuticsAnne Katrin Schlag, Saoirse E O'Sullivan, Rayyan R Zafar, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary CareJames C. Ballenger, Jonathan R. T. Davidson, Yves Lecrubier, et al.
The Lancet. Psychiatry|September 12, 2015
Attacks on antidepressants: signs of deep-seated stigma?David J Nutt, Guy M Goodwin, Dinesh Bhugra, et al.
Pageof 39